Growth Metrics

Palisade Bio (PALI) Non-Current Receivables (2016 - 2018)

Palisade Bio has reported Non-Current Receivables over the past 3 years, most recently at $298238.0 for Q4 2018.

  • Quarterly Non-Current Receivables fell 18.39% to $298238.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $298238.0 through Dec 2018, down 18.39% year-over-year, with the annual reading at $298238.0 for FY2018, 18.39% down from the prior year.
  • Non-Current Receivables was $298238.0 for Q4 2018 at Palisade Bio, up from $290354.0 in the prior quarter.
  • Over five years, Non-Current Receivables peaked at $424240.0 in Q4 2016 and troughed at $290354.0 in Q3 2018.
  • The 3-year median for Non-Current Receivables is $360815.0 (2017), against an average of $362131.7.
  • Year-over-year, Non-Current Receivables fell 13.86% in 2017 and then decreased 18.48% in 2018.
  • A 3-year view of Non-Current Receivables shows it stood at $424240.0 in 2016, then dropped by 13.86% to $365456.0 in 2017, then dropped by 18.39% to $298238.0 in 2018.
  • Per Business Quant, the three most recent readings for PALI's Non-Current Receivables are $298238.0 (Q4 2018), $290354.0 (Q3 2018), and $343281.0 (Q2 2018).